Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 111.50 | 0.0179 | -0.8328 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 111.50 | 0.0179 | -0.8328 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 111.50 | 0.0179 | -0.8328 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 4.00 | 111.50 | 0.0359 | -0.7435 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 145.00 | 111.50 | 1.3004 | 1.3521 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 120.00 | 111.50 | 1.0762 | 1.0928 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 156.25 | 36.27 | 98.00 | 111.50 | 0.8789 | 0.8469 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 156.25 | 36.27 | 123.00 | 111.50 | 1.1031 | 1.1249 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 125.00 | 111.50 | 1.1211 | 1.1462 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 156.25 | 36.27 | 131.00 | 111.50 | 1.1749 | 1.2092 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 156.25 | 36.27 | 69.00 | 111.50 | 0.6188 | 0.4873 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 151.00 | 111.50 | 1.3543 | 1.4117 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 156.25 | 36.27 | 153.00 | 111.50 | 1.3722 | 1.4313 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 170.00 | 111.50 | 1.5247 | 1.5947 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 156.25 | 36.27 | 88.00 | 111.50 | 0.7892 | 0.7282 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 156.25 | 36.27 | 137.00 | 111.50 | 1.2287 | 1.2711 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 121.00 | 111.50 | 1.0852 | 1.1035 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 156.25 | 36.27 | 97.00 | 111.50 | 0.8700 | 0.8352 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 86.00 | 111.50 | 0.7713 | 0.7038 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 120.00 | 111.50 | 1.0762 | 1.0928 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 156.25 | 36.27 | 78.00 | 111.50 | 0.6996 | 0.6042 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 51.00 | 111.50 | 0.4574 | 0.2341 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 156.25 | 36.27 | 127.00 | 111.50 | 1.1390 | 1.1673 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 97.00 | 111.50 | 0.8700 | 0.8352 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 156.25 | 36.27 | 103.00 | 111.50 | 0.9238 | 0.9045 |